Bon Natural Life Ltd Logo

Bon Natural Life Ltd

Bio-manufactures natural plant ingredients for fragrances, supplements, and immunity solutions.

BON | NDAQ

Overview

Corporate Details

ISIN(s):
KYG144921056
LEI:
Country:
United States of America
Address:
ROOM 601, BLOCK C, GAZELLE VALLEY, NO.69, 710076 SHAANXI
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bon Natural Life Ltd. is a biotechnology company that engages in the research, development, manufacturing, and sale of functional active ingredients extracted from natural plants and herbs. The company's core business involves processing these chemical compounds into ingredients for use in consumer products. Its primary product lines include personal care ingredients, such as plant-extracted fragrance compounds supplied to perfume and fragrance manufacturers, and ingredients for natural health supplements and functional foods. The company focuses on bio-manufacturing natural products and health solutions, with an emphasis on immunity-related applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Bon Natural Life Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bon Natural Life Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bon Natural Life Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CURIS INC Logo
Biotech developing innovative cancer therapeutics for hematologic malignancies.
United States of America CRIS
Curocell Inc. Logo
Biotech developing enhanced CAR-T therapies for cancer using its OVIS™ platform.
South Korea 372320
CYBIN INC. Logo
A clinical-stage firm engineering novel psychedelic drugs for depression and anxiety.
United States of America CYBN
Cyclerion Therapeutics, Inc. Logo
Developing personalized therapy for TRD with a biofeedback device and anesthetics.
United States of America CYCN
Cyfuse Biomedical K.K. Logo Japan 4892
CYTOKINETICS INC Logo
Late-stage biopharma developing muscle-modulating drugs for heart and neuromuscular diseases.
United States of America CYTK
CytoMed Therapeutics Ltd Logo
Develops off-the-shelf cell immunotherapies using γδ T cells & NK cells for cancer treatment.
United States of America GDTC
CytomX Therapeutics, Inc. Logo
Develops tumor-activated antibody therapeutics for more targeted, less toxic cancer treatments.
United States of America CTMX
Daebonglsco.,Ltd Logo
Develops raw materials and APIs for the personal care, pharmaceutical, and food industries.
South Korea 078140
DaehanPharmaceutical Logo
Develops and manufactures pharmaceuticals and health foods for human and animal markets worldwide.
South Korea 023910

Talk to a Data Expert

Have a question? We'll get back to you promptly.